Cheng‐Shyong Chang
- Hepatology top 10%
- Hepatitis C virus research 4
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 3
- Gastroenterology top 10%
-
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Hepatitis B Virus Studies 3
- Liver Disease Diagnosis and Treatment 3
-
- Eosinophilic Disorders and Syndromes 3
-
- Fullerene Chemistry and Applications 3
- Co-authors
- Shou‐Tung ChenWen‐Yau HsuNicholas C. HsuDar‐Ren ChenHwei‐Fang TienJih‐Luh TangShang‐Yi HuangYao‐Chang Chen
- Cited by
- HepatologyHematologyGastroenterology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (6 papers)Cancer (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Cheng‐Shyong Chang
41 papers receiving 541 citations
Peers
Comparison fields: 5 of 85
- Hepatology 95
- Hematology 103
- Gastroenterology 39
- Oncology 150
- Biochemistry 31
Countries citing papers authored by Cheng‐Shyong Chang
This map shows the geographic impact of Cheng‐Shyong Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Shyong Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Shyong Chang more than expected).
Fields of papers citing papers by Cheng‐Shyong Chang
This network shows the impact of papers produced by Cheng‐Shyong Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Shyong Chang. The network helps show where Cheng‐Shyong Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng‐Shyong Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 13 | |
| 7 | 2020 | 9 | |
| 8 | 2018 | 8 | |
| 9 | 2018 | 67 | |
| 10 | 2016 | 7 | |
| 11 | 2015 | 1 | |
| 12 | 2012 | 31 | |
| 13 | 2009 | 3 | |
| 14 | 2009 | 23 | |
| 15 | 2007 | 18 | |
| 16 | 2007 | 36 | |
| 17 | 2007 | 18 | |
| 18 | 2003 | 8 | |
| 19 | 1998 | 95 | |
| 20 | 1991 | 16 |
About Cheng‐Shyong Chang
Cheng‐Shyong Chang is a scholar working on Hematology, Genetics and Hepatology, having authored 44 papers that have together received 554 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Hepatitis C virus research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hepatitis B Virus Studies (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Fullerene Chemistry and Applications (3 papers). The work is most often cited by research in Hepatology (95 citations), Hematology (103 citations) and Gastroenterology (39 citations). Cheng‐Shyong Chang has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Shou‐Tung Chen, Wen‐Yau Hsu, Nicholas C. Hsu, Dar‐Ren Chen, Hwei‐Fang Tien, Jih‐Luh Tang, Shang‐Yi Huang, Yao‐Chang Chen, Tsung‐Li Kuo and Wen‐Chien Chou. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.